OPIPZA is an atypical antipsychotic indicated for:

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS

See full prescribing information for complete boxed warning.

  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. OPIPZA is not approved for the treatment of patients with dementia-related psychosis.
  • Increased risk of suicidal thinking and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors.

Ask your healthcare provider if OPIPZA™ is right for you.

Please see our exclusive savings offer for OPIPZA™.

Learn more about
OPIPZA™

OPIPZA™ Rebate

Get Started Today

Location

1301 HWY 36, Ste 11,
Hazlet, NJ 07730 USA

Our hours

9:00 AM – 5.00 PM
Monday – Friday

Contact us

Phone: 844.700.5011
Fax: 732.344.6155
Email: contact@carwinpharma.com